Free Trial

Short Interest in ASP Isotopes Inc. (NASDAQ:ASPI) Increases By 13.8%

ASP Isotopes logo with Basic Materials background

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) was the target of a significant growth in short interest in December. As of December 31st, there was short interest totalling 6,770,000 shares, a growth of 13.8% from the December 15th total of 5,950,000 shares. Based on an average daily volume of 5,090,000 shares, the days-to-cover ratio is presently 1.3 days. Currently, 14.6% of the company's stock are sold short.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Canaccord Genuity Group reissued a "buy" rating and issued a $4.50 price target on shares of ASP Isotopes in a research report on Friday, October 18th. Canaccord Genuity Group assumed coverage on shares of ASP Isotopes in a research report on Friday, October 4th. They issued a "buy" rating and a $4.50 price target for the company.

Check Out Our Latest Stock Analysis on ASP Isotopes

ASP Isotopes Stock Up 10.1 %

NASDAQ:ASPI traded up $0.52 during mid-day trading on Friday, reaching $5.66. The stock had a trading volume of 2,735,525 shares, compared to its average volume of 2,112,098. The business's 50 day moving average is $5.51 and its 200 day moving average is $4.08. ASP Isotopes has a fifty-two week low of $1.86 and a fifty-two week high of $9.33. The stock has a market cap of $404.07 million, a P/E ratio of -9.28 and a beta of 3.48. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54.

Hedge Funds Weigh In On ASP Isotopes

A number of hedge funds have recently added to or reduced their stakes in the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new position in ASP Isotopes in the third quarter worth approximately $6,249,000. Telemark Asset Management LLC acquired a new position in ASP Isotopes in the third quarter worth approximately $4,726,000. Geode Capital Management LLC increased its holdings in ASP Isotopes by 42.7% in the third quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company's stock worth $3,110,000 after buying an additional 334,836 shares during the last quarter. Philadelphia Financial Management of San Francisco LLC increased its holdings in ASP Isotopes by 158.3% in the third quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company's stock worth $2,757,000 after buying an additional 607,893 shares during the last quarter. Finally, State Street Corp grew its holdings in ASP Isotopes by 12.8% during the third quarter. State Street Corp now owns 853,695 shares of the company's stock valued at $2,373,000 after purchasing an additional 96,604 shares during the last quarter. Institutional investors and hedge funds own 16.80% of the company's stock.

About ASP Isotopes

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Read More

Should You Invest $1,000 in ASP Isotopes Right Now?

Before you consider ASP Isotopes, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.

While ASP Isotopes currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines